4.5 Article

Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Peripheral Vascular Disease

Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction

Sadayoshi Ito et al.

Summary: Esaxerenone, a mineralocorticoid receptor blocker, showed effective antihypertensive effects and good tolerability in Japanese hypertensive patients with moderate kidney dysfunction, with consistent results across patient subgroups. The drug successfully reduced blood pressure and was well tolerated, with transient increases in serum K+ levels observed in some patients but no cases requiring treatment discontinuation due to kidney function decline.

HYPERTENSION RESEARCH (2021)

Article Peripheral Vascular Disease

Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism

Ryo Nakamaru et al.

Summary: The study found that female patients with bilateral primary aldosteronism have worse renal outcomes compared to male patients after receiving mineralocorticoid receptor antagonist treatment. Despite similar systolic blood pressure levels between the sexes, women experienced a greater decline in estimated glomerular filtration rate, especially during the late phase of 6 to 60 months post-treatment initiation.

HYPERTENSION (2021)

Review Medicine, General & Internal

Diagnosis and treatment of primary aldosteronism: practical clinical perspectives

W. F. Young

JOURNAL OF INTERNAL MEDICINE (2019)

Article Peripheral Vascular Disease

Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term

Gian Paolo Rossi et al.

HYPERTENSION (2018)

Article Endocrinology & Metabolism

Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study

Gregory L. Hundemer et al.

LANCET DIABETES & ENDOCRINOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice

Silvia Monticone et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Endocrinology & Metabolism

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

John W. Funder et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Endocrinology & Metabolism

Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism

Paolo Mulatero et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Review Peripheral Vascular Disease

Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications

Graziela Z. Kalil et al.

HYPERTENSION RESEARCH (2012)

Article Medicine, General & Internal

Age As a Risk Factor

Ravi Dhingra et al.

MEDICAL CLINICS OF NORTH AMERICA (2012)

Article Endocrinology & Metabolism

Guidelines for the diagnosis and treatment of primary aldosteronism - The Japan Endocrine Society 2009

Tetsuo Nishikawa et al.

ENDOCRINE JOURNAL (2011)

Article Urology & Nephrology

Revised Equations for Estimated GFR From Serum Creatinine in Japan

Seiichi Matsuo et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2009)

Article Cardiac & Cardiovascular Systems

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

P Milliez et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)

Article Peripheral Vascular Disease

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension

MH Weinberger et al.

AMERICAN JOURNAL OF HYPERTENSION (2002)

Review Peripheral Vascular Disease

Gender differences in the regulation of blood pressure

JF Reckelhoff

HYPERTENSION (2001)